Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

HYDROXYPROGESTERONE CAPROATE for Foetal exposure during delivery: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 45 adverse event reports in the FDA FAERS database where HYDROXYPROGESTERONE CAPROATE was used for Foetal exposure during delivery.

Most Reported Side Effects for HYDROXYPROGESTERONE CAPROATE

Side Effect Reports % Deaths Hosp.
Premature delivery 4,322 19.1% 5 2,874
Premature baby 3,930 17.4% 187 2,161
Injection site pain 2,572 11.4% 1 52
Injection site pruritus 1,841 8.2% 0 31
Product dose omission issue 1,663 7.4% 0 110
Inappropriate schedule of product administration 1,164 5.2% 2 200
Product administration error 972 4.3% 0 64
Injection site swelling 924 4.1% 0 16
Injection site mass 829 3.7% 0 8
Injection site erythema 743 3.3% 0 19
Preterm premature rupture of membranes 694 3.1% 1 622
Uterine contractions during pregnancy 689 3.1% 0 235
Premature labour 669 3.0% 2 522
Product dose omission 612 2.7% 2 127
Stillbirth 542 2.4% 520 12

Other Indications for HYDROXYPROGESTERONE CAPROATE

Premature delivery (12,780) Foetal exposure during pregnancy (4,042) Product used for unknown indication (3,597) Exposure during pregnancy (894) Premature labour (753) Pregnancy (162) Prophylaxis (98) Prenatal care (50) Postponement of preterm delivery (44) Premature baby (41)

Related Pages

HYDROXYPROGESTERONE CAPROATE Full Profile All Foetal exposure during delivery Drugs HYDROXYPROGESTERONE CAPROATE Demographics HYDROXYPROGESTERONE CAPROATE Timeline